Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stereotaxis Inc (NASDAQ:STXS)

1.48
Delayed Data
As of 1:44pm ET
 -0.3201 / -17.78%
Today’s Change
0.65
Today|||52-Week Range
3.61
-0.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$37.9M

Company Description

Stereotaxis, Inc. engages in the design, manufacture, and marketing of robotic systems and instruments that electrophysiologists use for the treatment of abnormal heart rhythms known as cardiac arrhythmias. The company was founded in June 1990 and is headquartered in St. Louis, MO.

Contact Information

Stereotaxis, Inc.
4320 Forest Park Avenue
St. Louis Missouri 63108
P:(314) 678-6100
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

William C. MillsChairman & Chief Executive Officer
Martin C. StammerChief Financial Officer & Head-Investor Relations
Karen Witte DurosSecretary, Senior Vice President & General Counsel
Frank J. ChengSVP-Marketing & Business Development
David A. GiffinVice President-Human Resources